Instem's full year results to be behind expectations, shares plunge
21st Nov 2016 10:10
(ShareCast News) - Shares in Instem plunged on Monday after the healthcare computer services company warned full year results would be behind expectations as its clinical business had "further deteriorated" from the first half of the year. Instem Clinical has been hit by a slowdown in the clinical m
Read moreInstem shares up as revenue rises and earnings fall
19th Sep 2016 11:08
(ShareCast News) - Healthcare IT solutions company Instem announced its unaudited half year results for the six months to 30 June on Monday, with revenues increasing 21% to £9.1m and recurring revenues rising 6% to £5.3m. The AIM-traded firm reported an EBITDA increase of 34% to £1.2m, with adjusted
Read moreInstem acquires Notocord in EUR 4.2m deal
5th Sep 2016 16:00
(ShareCast News) - Provider of IT solutions to the global early development healthcare market, Instem, announced on Monday that it has acquired Notocord. The AIM-traded firm said the total consideration, to be satisfied in cash, will be up to €4.2m, net of any cash acquired adjusted for a normalised
Read moreInstem wins two more SEND orders for Submit platform
15th Mar 2016 11:46
(ShareCast News) - Instem has won a pair of contracts for its Submit software platform, which helps the drug development industry comply with the US regulator's new data initiative. AIM-listed Instem said the two new contracts with existing 'top 25' global pharmaceutical customers were worth a combi
Read moreInstem on track to meet target after FDA boosts outlook
12th Jan 2015 14:47
Strong order intake has seen IT supplier Instem begin 2015 with its largest ever opening sales backlog. The firm, which supplies IT applications to drug developers, said it expects to meet full year's expectations for 2014 after a "very encouraging" final quarter. House broker Singer N+1 said this
Read moreBuoyant Instem sees improvement in end markets
26th Mar 2014 15:50
Shares in Instem, a provider of IT systems to preclinical biotech companies, rose on encouraging results for 2013 and news that its end-markets were returning to health. The AIM-listed company drove adjusted earnings up 10.3% to 8.6p per share on a 8% increase in adjusted operating profit to £8.2m
Read moreIT group Instem secures contract extension
26th Mar 2014 07:54
AIM-listed IT company Instem has won a contract extension with the US National Institute of Health for its provantis pre-clinical software suite. The group, which operates in the health department, also plans to add two further operational sites and 100 further Provantis users. Provantis is a Wind
Read moreInstem wins three-year deal with pharmaceutical group
20th Feb 2014 12:45
AIM-listed Instem, an IT solutions provider, has scored a three-year contract with a global pharmaceutical organisation for its Animal Care Information System (ACIS). The contract, worth $0.2m a year, will contribute to the firm's Software-as-a-Service (SaaS) revenues. The ACIS software solution
Read moreInstem shares soar following US government contract win
28th Feb 2013 11:36
Shares in Instem leapt by a third on Thursday after the software provider revealed that the National Institute of Environmental Health Sciences (NIEHS) has purchased its Provantis 9 preclinical software suite via SaaS [Software-as-a-Service] to support National Toxicology Programme (NTP) studies.
Read more